These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6744551)

  • 1. Dynamic variability of binding of antiarrhythmic drugs during the evolution of acute myocardial infarction.
    Kessler KM; Kissane B; Cassidy J; Pefkaros KC; Kozlovskis P; Hamburg C; Myerburg RJ
    Circulation; 1984 Sep; 70(3):472-8. PubMed ID: 6744551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute changes in serum binding of disopyramide and flecainide after myocardial infarction.
    Caplin JL; Johnston A; Hamer J; Camm AJ
    Eur J Clin Pharmacol; 1985; 28(3):253-5. PubMed ID: 4007029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.
    Garfinkel D; Mamelok RD; Blaschke TF
    Ann Intern Med; 1987 Jul; 107(1):48-50. PubMed ID: 3109296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of alpha-1-acid glycoprotein and its relation to myocardial enzymes after acute myocardial infarction.
    Giardina EG; Raby K; Freilich D; Vita J; Brem R; Louie M
    Am J Cardiol; 1985 Aug; 56(4):262-5. PubMed ID: 4025163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered protein binding of quinidine in patients with atrial fibrillation and flutter.
    McCollam PL; Crouch MA; Watson JE
    Pharmacotherapy; 1997; 17(4):753-9. PubMed ID: 9250553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical implication of changing unbound quinidine levels.
    Kessler KM; Wozniak PM; McAuliffe D; Terracall E; Kozlovskis P; Mahmood I; Zaman L; Trohman RG; Castellanos A; Myerburg RJ
    Am Heart J; 1989 Jul; 118(1):63-9. PubMed ID: 2741797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for prophylactic use of antiarrhythmic drugs in acute myocardial infarction.
    Halkin H
    Cardiovasc Clin; 1974; 6(2):119-29. PubMed ID: 4613455
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma concentrations of antiarrhythmic drugs (author's transl)].
    Kasanuki H; Hirosawa K
    Kokyu To Junkan; 1977 May; 25(5):383-91. PubMed ID: 560038
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of amiodarone on serum quinidine and procainamide levels.
    Saal AK; Werner JA; Greene HL; Sears GK; Graham EL
    Am J Cardiol; 1984 May; 53(9):1264-7. PubMed ID: 6711425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
    Kim SY; Benowitz NL
    Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drug monitoring.
    Howanitz JH; Howanitz PJ
    Clin Lab Med; 1981 Sep; 1(3):501-22. PubMed ID: 6179688
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
    David BM; Ilett KF; Whitford EG; Stenhouse NS
    Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of serum alpha 1-acid glycoprotein changes in acute myocardial infarction.
    Chapelle JP; Albert A; Smeets JP; Heusghem C; Kulbertus HE
    Clin Chim Acta; 1981 Sep; 115(2):199-209. PubMed ID: 7285365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Serum levels in evaluating antidysrhythmic therapy.
    Van Durme J; Bogaert MG
    Circulation; 1974 Dec; 50(6):1284. PubMed ID: 4430125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.